Paul E Harris

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Vaccines

Scientific reports

International journal of molecular sciences

Columbia University

Weill Cornell Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Columbia University Sep 01 1988

United States

Associate Professor :: Medicine

Rockefeller University Sep 01 1985 - Jun 01 1988

United States

Postdoctoral Fellow :: Biochemistry / Peptide chemistryy

Education History

Weill Cornell Medical College Sep 01 1980 - Jun 01 1985

United States

PHD :: MSKCC Hematopoiesis

Publications

Paul E Harris, Scott Burkholz, Charles V Herst, Reid M Rubsamen
Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine. Vaccines 12 (3) (2024)
Paul E Harris, Scott Burkholz, Charles V Herst, Reid M Rubsamen
Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine. Vaccines 12 (3) (2024)
Paul E Harris, Scott Burkholz, Charles V Herst, Reid M Rubsamen
Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine. Vaccines 12 (3) (2024)
Scott R Burkholz, Charles V Herst, Richard T Carback, Paul E Harris, Reid M Rubsamen
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study. Vaccines 11 (3) (2023)
Sharon Wright, Scott R Burkholtz, Cathy Zelinsky, Connor Wittman, Richard T Carback, Paul E Harris, Tikoes Blankenberg, Charles V Herst, Reid M Rubsamen
Survivin Expression in Luminal Breast Cancer and Adjacent Normal Tissue for Immuno-Oncology Applications. International journal of molecular sciences 24 (14) (2023)
Scott R Burkholz, Charles V Herst, Richard T Carback, Paul E Harris, Reid M Rubsamen
Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study. Vaccines 11 (3) (2023)
Paul E Harris, Trevor Brasel, Christopher Massey, C V Herst, Scott Burkholz, Peter Lloyd, Tikoes Blankenberg, Thomas M Bey, Richard T Carback, Thomas Hodge, Serban Ciotlos, Lu Wang, Jason E Comer, Reid M Rubsamen
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques. Vaccines 9 (5) (2021)
Stevan Pecic, Nenad Milosavic, Gina Rayat, Antonella Maffei, Paul E Harris
A novel optical tracer for VMAT2 applied to live cell measurements of vesicle maturation in cultured human β-cells. Scientific reports 9 (1) (2019)

Paul E Harris.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Paul E Harris